By combining these three perspectives, we can build models of microbiomes that can be used to predict responses to host changes such as diet, weight gain, or disease.
Meta'omics technologies and single-cell sequencing offer unparalleled new tools for learning about the human microbiome. As our technical capabilities progress, we can shift more of our focus to modeling the effects of the human microbiome on our health. Eventually, these tools can shed light on the dynamics that shape the microbiome from infancy through adulthood, how the microbiome as a community responds to perturbations such as dietary shifts, disease, or antibiotic treatment, and how the microbiome can be measured to predict disease and altered to treat it.
Taxonomy: the Composition of Microbial Communities
Until DNA sequencing technology revolutionized microbial community analysis, microbial ecologists were limited to studying microbes that either could be cultivated or identifıed by staining. Early use of DNA sequencing was limited almost exclusively to the 16S ribosomal RNA (rRNA) gene because much of its sequence is nearly identical across species. However, 10 variable regions with higher mutation rates are useful for distinguishing different taxa, enabling the creation of phylogenetic trees (Fig. 1) .
Because this technique amplifıes only a single gene, it is both simple and relatively inexpensive to use, and its cost continues to come down. Although powerful, however, 16S gene sequencing does not distinguish between bacterial strains with very similar 16S rRNA gene sequences-for example, between the closely-related Escherichia and Shigella genera. Nor does it describe community functions.
However, as sequencing costs decreased substantially, whole metagenome sequencing (WMS), or sequencing of all community DNA, became feasible. Like 16S, WMS can describe which taxonomic categories are represented in different samples, an approach called community Using meta'omic techniques to analyze microbial communities. Many different types of analyses can be done using samples from a microbial community, and each type of analysis can answer different questions. (Center) A microbial community can come from many different hosts and environments, and it produces many different products (DNA, RNA, proteins and metabolites), all of which can be isolated and studied in meta'omic analysis. All products affect the host environment, and changes in host environment in turn affect community composition and behavior. (Outer sections, counter-clockwise from top) Measuring community DNA allows the construction of phylogenetic relationships of microbes in the community and reveals the abundance of taxa. Single-cell genomic sequencing identifies different populations of cells and reveals small genomic differences. Functional profiles can also be calculated based on DNA analysis, and tend to be more stable than taxonomic profiles. Metabolite, protein, or mRNA abundances can be compared with DNA abundances to compare what the community is doing with what it is capable of doing. Meta'omic data can be used to construct interaction networks among taxa, genes, metabolites, or proteins. Finally, we can measure microbial effects on health by comparing meta'omic profiles of diseased and healthy people.
profıling (Fig. 1) . Knowing the abundance of each taxon in a sample allows us to compare communities in different environments. For instance, we can compare the species on aerobic, dry skin with those in anaerobic, moist stool; or the gut communities of obese and lean people. The taxonomic profıle for each sample is the percentage of sequences that fall into each taxonomic category, but the categories are determined differently for 16S and WMS data. In 16S sequencing, taxonomy is assigned by comparing each group of highly similar sequences to a reference database. In WMS sequencing, taxonomy is assigned by comparing either individual reads or assembled reads to reference genome databases. However, both processes are limited by the quality of the reference database-how many genomes are available and how well they represent the community.
At fırst, researchers sequenced microbial genomes of cultured isolates, but more recently they sometimes reconstruct genomes from WMS data. While read assembly from single-isolate ge- nomes is much simpler, many microbes cannot be cultured in isolation because their nutritional or environmental requirements are exacting or unknown. Metagenomic assembly circumvents these diffıculties, but requires many more sequencing reads to cover low-abundance taxa. Additional computational challenges arise from biological ambiguities such as horizontal gene transfers between unrelated taxa or sequences that are common to many taxa.
Single-cell sequencing sidesteps both these problems and helps to bridge gaps in reference genome databases (Fig. 2) . Although single-cell sequencing does not require culture or metagenomic assembly, it presents other technical challenges, such as development of specialized techniques for isolating individual, high-quality cells. Furthermore, because of the amplifıcation necessary to sequence such a small quantity of DNA, it is essential to prevent and identify contamination.
One important benefıt of single-cell sequencing is that it expands genomic databases to include more unculturable and rare microbes, in turn bolstering information about these microbes from meta'omics studies. Furthermore, single-cell sequencing provides highly detailed information about populations of cells, allowing us to identify subpopulations and individual strains within a sample (Fig. 1) . For example, WMS can uncover antibiotic-resistance genes in E. coli in the gut, but single-cell sequencing can show which individual E. coli cells have particular combinations of antibiotic resistance genes. Even more recently, synthetic long-read sequencing is offering an alternative means to single-cell sequencing for studying these population dynamics.
Function: What Microbial Communities Are Doing
While we can view microbiomes as collections of taxa, and observe how taxonomic profıles relate to patient characteristics such as diet and disease, we can also examine microbiomes from other perspectives. For example, they can be characterized in terms of their metabolic or functional capabilities. Thus, the fundamental unit of the microbiome could be either a taxon or a biochemical function.
Functional profıling tells us about the potential capabilities of the community by identifying genes within WMS sequences, either by searching them for sequences that resemble genes or by mapping them to reference databases of known genes. With such information, we can ask how these potential functions of a community change across different body sites or between disease and healthful states (Fig. 1) . For example, stool is abundant in genes for metabolizing complex carbohydrates, while the oral cavity microbiome is rich in genes for metabolizing simple sugars, according to researchers working on the Human Microbiome Project (HMP). They also found that gene functional capabilities are more stable than species compositions across individuals, supporting the idea that overall community function is more important than are individual species within the human microbiome.
Knowing the sequence of a microbial genome tells us its capabilities, not which genes will be expressed in any particular situation. Thus, other meta'omics technologies are needed to understand how the microbiome reacts to its environment by measuring more transient community properties, such as which genes are being expressed or which molecules are being secreted. Specifıcally, metatranscriptomics provides a snapshot of gene expression by quantifying microbial mRNA, while metabolomics and metaproteomics quantify the metabolites and proteins, respectively.
These pictures of community gene expression and end products are often blurred because all three techniques face unmet technical challenges. For example, samples typically contain more tRNA and rRNA than mRNA, complicating efforts to determine mRNA sequences. Furthermore, in host-associated microbial communities, separating host and microbial RNA can prove diffıcult because the percentage of microbial RNA varies depending on the anatomic site from which it comes. Finally, in metabolomics and metaproteomics, the data consist of spectroscopy peaks rather than sequences, making it diffıcult to identify and characterize end products.
Despite these challenges, meta'omic technologies provide us with a wealth of information. We can compare, for example, the DNA and mRNA abundance of a specifıc gene to determine whether it is over-or under-expressed compared to its abundance in the community (Fig. 1) . Some genes, such as those for producing methane in the gut, are present at low levels but are very highly transcribed, while others, such as those for synthesizing phenylalanine and tryptophan in the gut, are present at relatively high abundance but rarely transcribed in individuals who eat highprotein diets.
We can also compare the metagenomes of healthy and diseased people to their corresponding metatranscriptomic and metaproteomic profıles to link differences in genetic potential with differences in what is being expressed and produced by the community. Knowing how taxonomy and function change between healthy and diseased states leads us to a third question: how do these changes occur?
Ecology: How Microbes Interact with One Another and their Hosts
A third way to characterize microbial communities is to consider them deterministic systems with measurable interactions and effects. Such systems can be characterized by measuring within-microbiome interactions as well as the reciprocal effects that the microbiome and host exert on each other (Fig. 1) . Mathematical modeling can then help to predict the effects of interventions on the microbiome, in turn helping to identify treatments that prevent or cure disease. To build such models, we must measure interactions and effects, and iteratively validate these measurements and predictions.
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Huttenhower: from Teaching Computers to Read to Teaching Them about Microbes
Curtis Huttenhower blames a series of "goofy" computer games for getting him hooked on problem solving in a data-driven environment. "I was a big fan of the Infocom games; Zork and Ballyhoo were what got me into language processing," he says. Much later, during graduate school, he extended that interest in computers to harnessing them to analyze the human microbiome. "That was something I stumbled on during the later stages of my Ph.D. that seemed like it would be a good computational challenge."
Today, Huttenhower, associate professor of computational biology and bioinformatics at Harvard University, works on the Human Microbiome Project and co-leads the Center for Characterizing the Gut Microbial Ecosystem in Inflammatory Bowel Disease. More broadly, members of his research group are developing computational methods for mining large-scale genomic and metagenomics data resources, he says. "My overall goals are. . .first, diagnostics: can we use the microbiome as a high-dimensional readout of host health to predict disease status, drug response, or other phenotypes [and] second, therapeutics: can we learn how to intervene with antibiotics, probiotics, or pharmaceuticals to shift the microbiome into 'healthier' states?" Huttenhower, 34, was born in Pittsburgh, but at 3, moved with his family to rural Maine, then, at 7, to Weirton, W.Va., and then to Wheeling, at about 11. His parents recently moved to Rhode Island, where his father directs the small business development program at the University of Rhode Island. His younger sister is a materials engineer in Connecticut.
At 15, Huttenhower left high school after his sophomore year to attend Simon's Rock College of Bard in Great Barrington, Mass. "High school wasn't an especially challenging academic environment, and I felt ready to start college-and it was a blast," he says. Two years later he transferred to Rose-Hulman Institute of Technology, where he earned his B.S. in 2000.
From there, he worked as a software design engineer for Microsoft in Redmond, Wash., before returning to school in 2002. Leaving industry to come back to academia was a hard decision, he recalls. However, doing so "makes it easier to advise students or postdocs thinking about industry positions, since there are different benefits and drawbacks. Huttenhower has a few interesting hobbies for his tooinfrequent spare time. He is an avid Dance Dance Revolution player, having learned it from the Japanese language team at Microsoft. "It's great exercise, and it literally takes years to get really good," he says. He also is a mid-distance, runner, enjoys hiking and camping, and reads a lot of science fiction, fantasy, and magical realism. To get away from technology for a while, he even once spent a vacation learning how to work a dairy farm. "I learned how to milk a cow and discussed antimicrobials and the gut microbiome with the owner," he says. He lives with his two cuts, Boy and Girl, and enjoys Boston's mix of downtown fun and nearby rural escapes.
We measure interactions and effects differently. To measure interactions, we search for correlations between two taxa, genes, transcripts, or metabolites in any type of meta'omic profıle describing the microbiome. To determine which correlations are signifıcant, statistical techniques must account for the complex structure of meta'omic data; this is an active area of research. To measure effects of the microbiome on the host and vice versa, we look for correlations between taxon, gene, transcript, or metabolite abundance with some host characteristic, such as diet or obesity. Because interactions and effects occur within the context of a host environment, measuring and interpreting them requires choosing a model system.
In general, researchers use one of three types of model systems for studying microbiomes: in vitro, animal, and human. In vitro systems are simple, culturing specifıc sets of taxa under particular conditions. Because the taxonomic profıle and environment are so tightly controlled, interactions within them can be measured very accurately. For example, the symbiosis of two taxa can be studied by growing them both separately and in co-culture under the same conditions, and measuring their growth rates, metatranscriptomes, and metabolomes.
Animal models resemble human biology more closely than can in vitro systems. In fact, many of the effects of the microbiome, such as its importance in immune system development, were fırst noted in animals systems. Animals such as mice are uniform, easy to colonize with specifıc bacteria, and easy to perturb by administering antibiotics or changing diet. In contrast to mice, the human diet, environment, and genetic makeup vary greatly among individuals. This variability presents challenges when applying what we learn in model systems to diverse human populations, meaning we need much larger numbers of subjects in human studies to detect potential effects of the microbiome on human health. Effects that are real rather than study artifacts should be reproducible across comparable studies.
When measuring microbiomes, differences in methodology can greatly influence measurements. For example, which variable region of the 16S rRNA gene is sequenced affects the resulting abundances of certain taxa. Furthermore, once reads are sequenced, bioinformatic choices affect results as well. Researchers now use at least 20 different tools, reliant on three distinct approaches, to profıle taxa. Deciding which tools are appropriate for which tasks would make it easier to compare studies. Further, it is crucial to compare different population groups to understand which microbiome effects are general and which are population specifıc.
Establishing effects is only part of the goal of characterizing relationships between the microbiome and human health. Another important goal is to predict the response of the microbiome to clinical interventions, a process that depends on developing well-validated models. This validation requires model systems that can be manipulated, and are replicable and inexpensive to use. Although results from studying in vitro model systems may be diffıcult to extrapolate to how microbiomes affect the human body, these systems are being matched more closely to human physiology, particularly the gut, by incorporating elements such as intestinal epithelial cells and simulated intestinal movement. With such refınements, we may more accurately describe the way multiple microbes interact with one another to form biofılms, the kinetics of diffusion for small molecules and microbes in human-associated habitats such as the mouth or gut.
Although we understand much about the flow of nutrients such as carbon and nitrogen on a macro-ecological scale, we still have much to learn about the physical and ecological dynamics that shape our microbiomes.
